Loading…
Balchem Corporation is projected to rise to $180.49 by 2027, a +11% move from its current price of $162.15. BCPC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $160.78 | $162.15 | $163.53 | 0.00% |
| Jul 14 | $160.22 | $162.15 | $164.11 | 0.00% |
| Jul 15 | $159.79 | $162.16 | $164.56 | 0.00% |
| Jul 16 | $159.43 | $162.16 | $164.94 | +0.01% |
| Jul 17 | $159.11 | $162.16 | $165.27 | +0.01% |
| Jul 18 | $158.83 | $162.16 | $165.57 | +0.01% |
| Jul 19 | $158.56 | $162.17 | $165.85 | +0.01% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $158.56 | $162.17 | $165.85 | +0.01% |
| Week 2 | $157.11 | $162.18 | $167.41 | +0.02% |
| Week 3 | $156.01 | $162.20 | $168.63 | +0.03% |
| Week 4 | $155.09 | $162.21 | $169.66 | +0.04% |
| Week 5 | $154.28 | $162.23 | $170.58 | +0.05% |
| Week 6 | $153.56 | $162.24 | $171.42 | +0.06% |
| Week 7 | $152.90 | $162.26 | $172.19 | +0.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Balchem Corporation is a Basic Materials company that develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.
The Human Nutrition & Health segment supplies ingredients in the food and beverage industry, with products including spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. It also offers specialty vitamin K2; microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications.
The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops.
It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Balchem Corporation (BCPC) is a Basic Materials stock currently priced at $165.92 per share and carrying a market cap of $5.33B. It holds a rank of 1326 among peers.
The multi-year forecast suggests meaningful upside from the 2026 base, with 2026 average priced at $165.92, rising to $267.23 in 2030, $583.80 in 2040, and $1,258.66 in 2050. Corresponding ROIs move from 0% in 2026 to 61.1% by 2030, 251.9% by 2040, and 658.6% by 2050, with sentiment evolving from Neutral in the near term to Bullish longer term.
The current price and forecast path position Balchem as a name with potential for sizable appreciation over the long horizon, albeit with inherent uncertainty and volatility implied by an annualized volatility of 20% listed in the data.
A major floor 8.5% below — a decisive break under it would weaken the trend.
The nearest floor, 3.6% below — buyers have tended to step in here.
The nearest ceiling, 5.6% above — a clean break opens room to run.
A major ceiling 12.6% above — clearing it would confirm fresh momentum.
Key BCPC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BCPC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $165.36 | Sell | $164.82 | Sell |
| MA 10 | $167.39 | Sell | $165.95 | Sell |
| MA 20 | $166.63 | Sell | $165.75 | Sell |
| MA 50 | $162.94 | Sell | $165.35 | Sell |
| MA 100 | $168.10 | Sell | $165.48 | Sell |
| MA 200 | $162.47 | Sell | $164.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.39 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -141.70 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.67 | Sell |
| ROC (12) | -2.34 | Sell |
| Bollinger %B (20,2) | 0.03 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.13 | Buy |
| Awesome (5,34) | 1.65 | Buy |
| Ultimate (7,14,28) | 26.39 | Buy |
| Momentum (10) | -7.08 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 163.42 | Sell |
| ADX (14) | 18.94 | Neutral |
| ATR (14) | 1.32 | Info |
The near-term technical picture is bullish. RSI14 is 60, indicating positive momentum without being overbought.
The stock is trading around the 50-day moving average of $165.25, above the 200-day moving average of $161.76, which supports a constructive near-term bias. Immediate support sits at $156.30, with resistance at $165.92.
Over the last 30 days, the price range has been from a low of $156.34 to a high of $176.09, suggesting the shares have room to move within a defined band before a clearer breakout or pullback.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $154.02 | $162.15 | $204.40 | 0% | Neutral | |
| $147.81 | $180.49 | $230.41 | +11% | Neutral | |
| $148.11 | $184.24 | $241.57 | +14% | Neutral | |
| $160.02 | $202.14 | $270.67 | +25% | Bullish | |
| $185.62 | $237.64 | $323.94 | +47% | Bullish | |
| $214.52 | $277.98 | $384.93 | +71% | Bullish | |
| $225.24 | $295.18 | $414.55 | +82% | Bullish | |
| $230.08 | $304.69 | $433.45 | +88% | Bullish | |
| $247.18 | $330.59 | $475.91 | +104% | Bullish | |
| $251.60 | $339.68 | $494.45 | +109% | Bullish | |
| $361.47 | $509.01 | $776.44 | +214% | Bullish | |
| $695.54 | $1,050.44 | $1,717.57 | +548% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $154.02 | $162.15 | $192.93 | +0.00% |
| August 2026 | $137.57 | $161.06 | $192.65 | -0.67% |
| September 2026 | $138.02 | $162.35 | $195.70 | +0.80% |
| October 2026 | $141.88 | $167.57 | $203.32 | +3.22% |
| November 2026 | $142.11 | $168.43 | $205.49 | +0.51% |
| December 2026 | $140.19 | $166.69 | $204.40 | -1.03% |
Click any year to see its month-by-month BCPC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, BCPC is projected to trade between $154.02 and $204.40, averaging $162.15 — a potential gain of 0% from today's $162.15. A consolidation phase looks the most probable path here.
Balchem Corporation's 2027 outlook centres on $180.49, within a $147.81 to $230.41 range. That is up +11% on the projected 2026 average. That marks a +11% change versus current levels. Price action looks broadly range-bound.
By 2028, BCPC could reach as high as $241.57, with a base case around $184.24 and support toward $148.11 — roughly +14% from $162.15. A consolidation phase looks the most probable path here.
Expect BCPC to range from $160.02 to $270.67 through 2029. The $202.14 average target implies a +25% move from current prices. That is up +10% on the projected 2028 average. Momentum favours further upside here.
The BCPC price prediction for 2030 points to an average of $237.64 (low $185.62, high $323.94) — a potential gain of +47% on today's $162.15. Buyers look set to stay in control over this stretch.
In 2031, BCPC is projected to trade between $214.52 and $384.93, averaging $277.98 — a potential gain of +71% from today's $162.15. That is up +17% on the projected 2030 average. Momentum favours further upside here.
Balchem Corporation's 2032 outlook centres on $295.18, within a $225.24 to $414.55 range. That is up +6% on the projected 2031 average. That marks a +82% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, BCPC could reach as high as $433.45, with a base case around $304.69 and support toward $230.08 — roughly +88% from $162.15. Momentum favours further upside here.
Expect BCPC to range from $247.18 to $475.91 through 2034. The $330.59 average target implies a +104% move from current prices. That is up +9% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The BCPC price prediction for 2035 points to an average of $339.68 (low $251.60, high $494.45) — a potential gain of +109% on today's $162.15. Momentum favours further upside here.
In 2040, BCPC is projected to trade between $361.47 and $776.44, averaging $509.01 — a potential gain of +214% from today's $162.15. That is up +50% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Balchem Corporation's 2050 outlook centres on $1,050.44, within a $695.54 to $1,717.57 range. That is up +106% on the projected 2040 average. That marks a +548% change versus current levels. Momentum favours further upside here.
Investing $1,000 in BCPC today (≈ 6.167129 BCPC) could be worth
$6,478.19
+$5,478.19 (+548%) by 2050 · US Dollar
Based on the average projected BCPC price of $1,050.44 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BCPCwould be worth at today's price.
$1,000 invested in BCPC on Jul 10, 2025 (≈ 6.175508 BCPC) would be worth
$1,001.36
+$1.36 (+0.1%) today · 1.00× · US Dollar
Based on a BCPC entry price of $161.93 vs. today's $162.15.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $168.8 | $960.6 | -3.9% |
| 1 month ago | $161.65 | $1,003.09 | +0.3% |
| 3 months ago | $174.93 | $926.94 | -7.3% |
| 6 months ago | $159.21 | $1,018.47 | +1.8% |
| 1 year ago | $161.93 | $1,001.36 | +0.1% |
| All time (5.0y) ago | $129.77 | $1,249.52 | +25.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BCPC forecast.
Our base-case forecast reaches $320.00 around 2034.
Implied market cap at $320.00: $10.28B
The multi-year forecast shows a strong long-run upside potential for Balchem. In 2030, the average price is projected to be $267.23, with a minimum of $208.60 and a maximum of $364.59, corresponding to an ROI of 61.1% and a bullish sentiment.
Looking further out, the 2040 forecast calls for an average of $583.80, a min of $414.41, and a max of $890.91, with an ROI of 251.9% and a bullish outlook.
By 2050, the average is expected to be $1,258.66, with a min of $833.14 and a max of $2,058.68, and an ROI of 658.6%, maintaining a bullish stance.
These figures are estimates and not guarantees; they reflect projected paths under the provided inputs and assume typical market conditions. The asset shows meaningful upside over the long term, but investors should consider the inherent uncertainties and potential for volatility, as indicated by an annualized volatility of 20% in the data.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $267.23 with a min of $208.60 and a max of $364.59, and an ROI of 61.1%. The sentiment for 2030 is BULLISH.
The forecast shows positive ROIs in multiple years, including 2030 (61.1%), 2040 (251.9%), and 2050 (658.6%), with a bullish sentiment from 2029 onward. However, forecasts are estimates, not guarantees, and risk factors should be considered.
The 2040 maximum in the forecast is $890.91, which is below $1,000, so reaching $1,000 by 2040 is not indicated by the provided numbers.
The current price is $165.92 per share and the market cap is $5.33B.
For 2050, the forecast shows an average price of $1,258.66, a minimum of $833.14, a maximum of $2,058.68, and an ROI of 658.6%, with a bullish sentiment.
Balchem Corporation Community Discussion
0Share your Balchem Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.